Clinical Trials Logo

Filter by:
NCT ID: NCT01227447 Recruiting - Clinical trials for Incontinence, Overactive Bladder, Stress Urinary Incontinence

Investigation of the Suburothelial Myofibroblast Network and of Smooth Muscle Function and Control in the Human Urinary Outflow Tract

Start date: January 2010
Phase: N/A
Study type: Observational

The aim is to find out if adreno-muscarinic synergy is present also in human tissues of the urinary outflow tract that have a dual adrenergic-muscarinic receptor fitting. To further characterise morphology and function of the suburothelial myofibroblast network in the human bladder outlet.

NCT ID: NCT01227304 Recruiting - Clinical trials for Prediction of Volume Responsiveness

SMOOCH - Small Volume Challenges to Predict Volume Responsiveness: Prospective Interventional Study

SMOOCH
Start date: July 2010
Phase: N/A
Study type: Interventional

- test for volume responsiveness - PiCCO-guided infusion over a pre-defined period of time

NCT ID: NCT01221779 Recruiting - Clinical trials for Post-Stroke Chronic Aphasia

Chronic Aphasia - Improved by Intensive Training and Electrical Brain Stimulation

CATS
Start date: January 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if non-invasive electrical brain stimulation can enhance the out of intensive language therapy in chronic aphasia

NCT ID: NCT01221493 Recruiting - Clinical trials for Solitary Pulmonary Nodule

EBUS Guided Cryo Biopsy of Solitary Pulmonary Nodules

Start date: April 2010
Phase: N/A
Study type: Interventional

To proof the feasibility and safety of EBUS guided transbronchial cryo biopsies in peripheral lung lesions

NCT ID: NCT01220544 Recruiting - Clinical trials for Acute Myeloid Leukemias

Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells

Start date: July 2001
Phase: Phase 1/Phase 2
Study type: Interventional

Experimental and clinical data suggest that alloreactive NK cells can reduce the risk of graft-rejection, GvHD and leukemic relapse after HLA-mismatched transplantation. The effectiveness of allogeneic NK cells is a function of HLA-differences between donor and recipient that give rise to NK cell clones which do not express inhibitory receptors matching for the HLA molecules of the recipient. Aim of the study is to evaluate cellular therapy with alloreactive, IL-2 activated NK cells after transplantation of T-cell depleted stem cell grafts from one haplotype mismatched family donors in patients with hematological malignancies.

NCT ID: NCT01216371 Recruiting - Clinical trials for Renal Cell Carcinoma

Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)

SMAT
Start date: October 2010
Phase: Phase 2
Study type: Interventional

The aim ist to identify biomarkers in the blood, to indicate early response or early treatment resistance.

NCT ID: NCT01212354 Recruiting - Clinical trials for Locally Advanced Head and Neck Cancer

Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT

Escalox
Start date: July 2015
Phase: Phase 3
Study type: Interventional

The major clinical problem and predominant cause of death after radio-oncological treatment of H+N cancers are loco-regional relapses. This randomized trial tests the hypothesis that dose escalated Intensity Modulated Radiotherapy (IMRT) selectively applied to the macroscopic primary tumor and involved neck nodes - which both in 80% - are hypoxic improves loco-regional control by at least 15% at 2 years. IMRT is combined with concurrent Cis-Platin chemotherapy. Tumor volume which correlates with number of malignant cells as well as tumor hypoxia are important biological parameters which increase radio-resistance, failure of local control and tumor progression. Basing on data of experimental and clinical radiation oncology we consider hypoxia as a useful parameter for pre-therapeutic strati-fication in future randomized radio-chemotherapy trials. In addition, hypoxia imaging by PET can be used for testing the significance of selective dose escalation on hypoxic tumor sub-volumes ("Dose Painting"). As a prerequisite for such innovative studies addressing hypoxia the translational part investigates the following key issues: correlation between the size of total tumor volume (primary, lymph nodes) and hypoxic sub-volume, the spatial shift of the hypoxic sub-volume before start of treatment and the correlation of loco-regional control and hypoxia. Before starting the main study a pre-study to assess the occurrence of radiation induced toxicities is mandatory to be performed. In a step-wise dose-escalation in a cohort-design the safety of dose-escalation should be determined. Step one: 6 patients Step two: 14 patients. In the pre-study the 1st group (6 patients) should be treated with 2.2 Gy up to 77.0 Gy for DEVPT and DEVLK. After evaluation of the toxicity the next 14 patients should be treated by this scheme.

NCT ID: NCT01209377 Recruiting - Clinical trials for Post-Traumatic Stress Disorder

Study of Eye Movement Desensitization and Reprocessing (EMDR) Working Mechanism

Start date: April 2010
Phase: N/A
Study type: Interventional

EMDR (Eye Movement Desensitization and Reprocessing) is an exposure-based procedure for the treatment of patients with post-traumatic stress disorder (PTSD). Although the efficiency of EMDR-treatment is empirically proven, it remains unclear whether the bilateral stimulation triggered via eye movements has specific effects on treatment outcome. Hypothesis explaining the efficacy of the EMDR treatment are: focussing on the moving hand triggers an orientation reaction, and the duality of alertness focus during trauma exposition causes a distraction of the traumatic topic. Within a randomized controlled study 120 patients will be treated during 8 therapeutical sessions with EMDR with bilateral stimulation or one of two control conditions: EMDR without bilateral stimulation (eyes on a fixed, unmoving hand) and exposition without any visual stimuli to focus attention on. Primary outcome are scores on an interview measure for PTSD symptoms (Clinician Administered PTSD Scale (CAPS))as assessed pre-treatment and after treatment (max 8 sessions of psychotherapy). The following hypothesis are investigated in the study: 1. EMDR treatment with bilateral stimulation through eye movements will be followed significant larger reduction in CAPS compared with EMDR treatment without bilateral stimulation (specific treatment effect of eye movements) 2. EMDR with eyes fixed will be followed by a significant larger reduction in CAPS compared with EMDR without external focus (specific treatment effect of distraction)

NCT ID: NCT01201096 Recruiting - Clinical trials for Neuroendocrine Tumors

Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE)

NEO-LEBE
Start date: September 2010
Phase: N/A
Study type: Observational

The purpose of this study is to show the tumor free long term survival of patients with isolated non-resectable liver metastases of neuroendocrine tumors after neo-adjuvant radio receptor treatment and following liver transplantation.

NCT ID: NCT01197092 Recruiting - Clinical trials for Diabetes Mellitus, Type II

The Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II

Start date: November 2010
Phase: Phase 2
Study type: Interventional

A treatment with the concept of mitochondrial medication developed by Dr Heinrich Kremer can demonstrably improve and successfully treat actual parameters of Diabetes Mellitus II as well as its risk factors.